In accordance with the NMPA approval, Gyre intends to pursue an adaptive Phase 2/3 clinical trial design, combining dose exploration with efficacy confirmation, to efficiently evaluate pirfenidone's ...
"One of the conversations I heard in the hallway was, 'What's going to happen to my research, my data? This is data that [is ...
7hOpinion
Medpage Today on MSNHow Doctors Can Adapt to the Digital Communication RevolutionLike it or not, this is the world we live in, and fact-checking, head-on debate, or claiming the moral high ground are often ...
2don MSN
Val Kilmer kept his throat cancer secret for several years. He died of pneumonia on Tuesday, more than 10 years after his ...
1don MSN
Superman (as played by David Corenswet) has seen better days.
The tests may have been carried out with good intentions but the reality represented some significant oversights, gaffs, and ...
Nuclear weapons can produce some of the most devastating destruction of any device ever created by humankind -- so what ...
Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round.
Today, 85% of children with cancer survive to adulthood and about 1 in 3 are left infertile from chemotherapy or radiation.
Company to showcase new Fire-Hazmat innovations at FDIC 2025, Indianapolis, as first EXO 8 Gamma area monitors ship to ...
A new trailer for "Superman" has dropped ... and, it's giving fans a longer look at Krypto the Superdog -- and, a peek inside ...
1d
News Medical on MSNClinical trial demonstrates safety of targeted treatment approach for deadly brain tumor in childrenA Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results